Juan Liberal-Martin - Publications

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

Journal: JCO global oncology

Published: August 13, 2026

Overcoming T cell exhaustion and senescence in CAR T cell therapy for solid tumors.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 27, 2026

Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors.

Journal: Journal of hematology & oncology

Published: March 25, 2026

Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 26, 2026

Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 26, 2026

Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 11, 2026

Immunotherapy and tyrosine kinase inhibitors in chordoma: a real-world data study from a European Reference Network on Rare Adult Solid Cancers member center.

Journal: Frontiers in oncology

Published: November 27, 2025

Inequities in enrollment across clinical trial phases and the need for a Spanish perspective.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 24, 2025

First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.

Journal: Journal for immunotherapy of cancer

Published: July 16, 2025

A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma).

Journal: ESMO open

Published: July 11, 2025

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

Journal: ESMO open

Published: June 16, 2025

Distant Metastasis of Merkel Cell Carcinoma: A Descriptive Study.

Journal: Dermatology practical & conceptual

Published: May 10, 2025